These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 26333529)

  • 21. Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies).
    Davison BA; Takagi K; Edwards C; Adams KF; Butler J; Collins SP; Dorobantu MI; Ezekowitz JA; Filippatos G; Greenberg BH; Levy PD; Masip J; Metra M; Pang PS; Ponikowski P; Severin TM; Teerlink JR; Teichman SL; Voors AA; Werdan K; Cotter G
    Am J Cardiol; 2022 Oct; 180():72-80. PubMed ID: 35933224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies.
    Davison BA; Metra M; Cotter G; Massie BM; Cleland JGF; Dittrich HC; Edwards C; Filippatos G; Givertz MM; Greenberg B; Ponikowski P; Voors AA; O'Connor CM; Teerlink JR;
    JACC Heart Fail; 2015 May; 3(5):395-403. PubMed ID: 25951761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Serelaxin in Patients with Acute Heart Failure.
    Metra M; Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Voors AA; Adams KF; Anker SD; Arias-Mendoza A; Avendaño P; Bacal F; Böhm M; Bortman G; Cleland JGF; Cohen-Solal A; Crespo-Leiro MG; Dorobantu M; Echeverría LE; Ferrari R; Goland S; Goncalvesová E; Goudev A; Køber L; Lema-Osores J; Levy PD; McDonald K; Manga P; Merkely B; Mueller C; Pieske B; Silva-Cardoso J; Špinar J; Squire I; Stępińska J; Van Mieghem W; von Lewinski D; Wikström G; Yilmaz MB; Hagner N; Holbro T; Hua TA; Sabarwal SV; Severin T; Szecsödy P; Gimpelewicz C;
    N Engl J Med; 2019 Aug; 381(8):716-726. PubMed ID: 31433919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF.
    Metra M; Davison BA; Gimpelewicz C; Carubelli V; Felker GM; Filippatos G; Greenberg BH; Hua TA; Liu Z; Pang PS; Ponikowski P; Severin TM; Voors AA; Wang Y; Cotter G; Teerlink JR
    Int J Cardiol; 2018 Feb; 253():91-96. PubMed ID: 29306479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure: Insights From the HF-ACTION Study.
    Sharma A; Stevens SR; Lucas J; Fiuzat M; Adams KF; Whellan DJ; Donahue MP; Kitzman DW; Piña IL; Zannad F; Kraus WE; O'Connor CM; Felker GM
    JACC Heart Fail; 2017 Oct; 5(10):724-734. PubMed ID: 28958347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.
    Anand IS; Kempf T; Rector TS; Tapken H; Allhoff T; Jantzen F; Kuskowski M; Cohn JN; Drexler H; Wollert KC
    Circulation; 2010 Oct; 122(14):1387-95. PubMed ID: 20855664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Serelaxin in Japanese Patients With Acute Heart Failure.
    Sato N; Takahashi W; Hirayama A; Ajioka M; Takahashi N; Okishige K; Wang X; Maki A; Maruyama H; Ebinger U; Yamaguchi M; Pang Y; Matsumoto H; Kawana M
    Circ J; 2015; 79(6):1237-47. PubMed ID: 25912697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial.
    Gimpelewicz C; Metra M; Cleland JGF; Szecsödy P; Chang Wun CC; Boer-Martins L; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Pang P; Ponikowski P; Severin T; Voors AA; Teerlink JR
    Am Heart J; 2017 Aug; 190():113-122. PubMed ID: 28760204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF.
    Voors AA; Davison BA; Felker GM; Ponikowski P; Unemori E; Cotter G; Teerlink JR; Greenberg BH; Filippatos G; Teichman SL; Metra M;
    Eur J Heart Fail; 2011 Sep; 13(9):961-7. PubMed ID: 21622980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serelaxin and acute heart failure.
    Tietjens J; Teerlink JR
    Heart; 2016 Jan; 102(2):95-9. PubMed ID: 26603680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure.
    Ponikowski P; Mitrovic V; Ruda M; Fernandez A; Voors AA; Vishnevsky A; Cotter G; Milo O; Laessing U; Zhang Y; Dahlke M; Zymlinski R; Metra M
    Eur Heart J; 2014 Feb; 35(7):431-41. PubMed ID: 24255129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study.
    Meyer S; Teerlink JR; Metra M; Ponikowski P; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Hua TA; Severin T; Qian M; Voors AA
    Clin Res Cardiol; 2017 Apr; 106(4):280-292. PubMed ID: 27838739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth-differentiation factor-15 and major cardiac events.
    Lin JF; Wu S; Hsu SY; Yeh KH; Chou HH; Cheng ST; Wu TY; Hsu WT; Yang CC; Ko YL
    Am J Med Sci; 2014 Apr; 347(4):305-11. PubMed ID: 24521768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial.
    Pagnesi M; Adamo M; Ter Maaten JM; Beldhuis IE; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Sama IE; Severin T; Gimpelewicz C; Voors AA; Teerlink JR; Metra M
    Eur J Heart Fail; 2023 Apr; 25(4):541-552. PubMed ID: 36915227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Plasma concentration of growth-differentiation factor-15 in children with congenital heart disease: relation ship to heart function and diagnostic value in heart failure].
    Li Y; Wang XM; Liu YL; Shi K; Yang YF; Guo YH
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Feb; 15(2):95-8. PubMed ID: 23428120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of age on clinical outcomes and response to serelaxin in patients with acute heart failure: An analysis from the RELAX-AHF-2 trial.
    Inciardi RM; Staal L; Davison B; Lombardi CM; Postmus D; Felker MG; Filippatos G; Greenberg B; Pang PS; Ponikowski P; Severin T; Gimpelewicz C; Teerlink J; Cotter G; Voors AA; Metra M
    Eur J Heart Fail; 2024 Sep; ():. PubMed ID: 39240040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct Comorbidity Clusters in Patients With Acute Heart Failure: Data From RELAX-AHF-2.
    Gomez KA; Tromp J; Figarska SM; Beldhuis IE; Cotter G; Davison BA; Felker GM; Gimpelewicz C; Greenberg BH; Lam CSP; Voors AA; Metra M; Teerlink JR; van der Meer P
    JACC Heart Fail; 2024 Oct; 12(10):1762-1774. PubMed ID: 38970586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between growth differentiation factor-15 and chronic heart failure in coronary atherosclerosis patients.
    Zhu ZD; Sun T
    Genet Mol Res; 2015 Mar; 14(1):2225-33. PubMed ID: 25867369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serelaxin : a potential new drug for the treatment of acute heart failure.
    Neverova N; Teerlink JR
    Expert Opin Investig Drugs; 2014 Jul; 23(7):1017-26. PubMed ID: 24865798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.